On March 14, 2023, BetterLife Pharma Inc. closed the transaction. The company has issued 1,500,000 units at a price of CAD 0.10 per unit for aggregate gross proceeds of CAD 150,000. The transaction included participation from Doroudian for 2,000,000 units for CAD 200,000.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0872 USD | +4.62% | -6.18% | +81.77% |
05-03 | BetterLife Pharma Inc. announced that it expects to receive CAD 0.5 million in funding | CI |
05-01 | BetterLife Pharma Advances IND-enabling Studies For BETR-001 | MT |
1st Jan change | Capi. | |
---|---|---|
+81.77% | 10.12M | |
+5.66% | 109B | |
+11.23% | 105B | |
-0.38% | 22.25B | |
-12.15% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-10.09% | 16.85B | |
+3.33% | 13.76B | |
+36.58% | 12.46B |
- Stock Market
- Equities
- BETRF Stock
- News BetterLife Pharma Inc.
- BetterLife Pharma Inc. announced that it has received CAD 0.15 million in funding